Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Drug Elimination by Renal Route: Tubular Secretion

Drug Elimination by Renal Route: Tubular Secretion

Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...

Surface Membrane Barriers

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...

Cholinergic Antagonists: Therapeutic Uses

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

Drug Elimination by Renal Route: Tubular Reabsorption

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Antimicrobial efficacy of cyanobacterium Synechococcus pevalekii extracts against MDR bacteria and fungi; an integrated GC-MS, molecular docking and MD simulation study.

Antonie van Leeuwenhoek·2026

Same author

Integrated bioactivity assessment of the cyanobacterium plectonema terebrans extract: an in vitro and in silico study.

Antonie van Leeuwenhoek·2026

Same author

Multicomponent synthesis of 2<i>H</i>-chromene-fused-thiazolo-triazole derivatives <i>via</i> cascade Michael addition/cyclization reaction: anticancer, antibacterial and computational evaluations.

RSC advances·2026

Same author

Design, synthesis, and biological evaluation of multifunctional dispiro chromeno-indenoquinoxaline hybrids as dual anticancer and antibacterial agents with metal-ion sensing ability.

RSC advances·2026

Same author

Synergistic Potential of Thalidomide and Hydroxyurea in Sickle Cell Disease Management: A Promising Combination Therapy.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion·2026

Same author

Probing the Conformation of BamC and BamE in Native Bacterial Membranes Using Solid-State NMR Spectroscopy.

Journal of the American Chemical Society·2026

Search research articles

Related Experiment Video

Updated: Jul 9, 2025

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

Prospective Phycocompounds for Developing Therapeutics for Urinary Tract Infection.

Ajit Kumar Bishoyi¹, Anjali Lakra¹, Chinmayee Priyadarsani Mandhata¹

¹Central Research Laboratory, Institute of Medical Sciences & Sum Hospital, Siksha 'O' Anusandhan Deemed to Be University, Bhubaneswar, Odisha, 751003, India.

Current Microbiology

|December 8, 2023

Summary

Antibiotic resistance poses a significant threat, with drug-resistant bacteria causing common infections like urinary tract infections (UTIs). This review explores natural products as potential treatments for these challenging bacterial infections.

More Related Videos

Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis

Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis

Published on: April 16, 2019

Detection of Tissue-resident Bacteria in Bladder Biopsies by 16S rRNA Fluorescence In Situ Hybridization

Detection of Tissue-resident Bacteria in Bladder Biopsies by 16S rRNA Fluorescence In Situ Hybridization

Published on: October 18, 2019

Related Experiment Videos

Last Updated: Jul 9, 2025

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis

Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis

Published on: April 16, 2019

Detection of Tissue-resident Bacteria in Bladder Biopsies by 16S rRNA Fluorescence In Situ Hybridization

Detection of Tissue-resident Bacteria in Bladder Biopsies by 16S rRNA Fluorescence In Situ Hybridization

Published on: October 18, 2019

Area of Science:

Microbiology
Pharmacology
Public Health

Background:

Antibiotic resistance in bacteria presents a growing global challenge, complicating treatment of common infections.
Nosocomial infections are increasingly prevalent, often caused by multidrug-resistant bacteria.
Urinary tract infections (UTIs) are a major public health concern, with rising rates of antibiotic resistance.

Purpose of the Study:

To provide a comprehensive update on UTI-associated diseases and their treatment challenges.
To highlight the global incidence of UTIs and the increasing prevalence of antibiotic resistance.
To explore the potential of natural products, specifically phycocompounds, in combating drug-resistant bacterial infections.

Main Methods:

Literature review and synthesis of recent research on antibiotic resistance and UTIs.
Analysis of global statistical data on UTI incidence and bacterial resistance patterns.
Examination of advancements in natural product research for antibacterial applications.

Main Results:

Antibiotic resistance is a critical issue in treating bacterial infections, including UTIs.
Natural products, particularly phycocompounds, show promise as novel antibacterial agents.
There is a need for new therapeutic strategies to combat multidrug-resistant bacteria.

Conclusions:

Urinary tract infections are common and increasingly difficult to treat due to antibiotic resistance.
Natural products offer a promising avenue for developing new antibacterial therapies.
Phycocompounds represent a potential source of novel antibacterial candidates for future drug development.